US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist
  • 4.520
  • -0.170-3.62%
Close Dec 20 16:00 ET
  • 4.600
  • +0.080+1.77%
Post 18:06 ET
87.33MMarket Cap-3.90P/E (TTM)

About Nuvectis Pharma Company

Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.

Company Profile

SymbolNVCT
Company NameNuvectis Pharma
Listing DateFeb 4, 2022
Issue Price5.00
Founded2020
CEOMr. Ron Bentsur
MarketNASDAQ
Employees13
Fiscal Year Ends12-31
Address1 Bridge Plaza,Suite 275,2nd floor
CityFort Lee
ProvinceNew Jersey
CountryUnited States of America
Zip Code07024
Phone1-201-614-3151
Websitehttp://nuvectis.com

Company Executives

  • Name
  • Position
  • Salary
  • Ron Bentsur
  • Chairman of the Board, Chief Executive Officer and President
  • 2.69M
  • Enrique Poradosu
  • Executive Vice President, Chief Scientific and Business Officer
  • 1.56M
  • Shay Shemesh
  • Executive Vice President, Chief Development and Operations Officer
  • 1.56M
  • Michael J. Carson
  • Vice President of Finance, Principal Financial and Accounting Officer
  • --
  • James F. Oliviero, III
  • Independent Director
  • 385.80K
  • Matthew L. Kaplan
  • Independent Director
  • 375.80K
  • Kenneth Hoberman
  • Independent Director
  • 385.80K
Heat List
US
Overall
Symbol
Price
% Chg

No Data